175 computational-cell-signaling-post-doc Postdoctoral positions at University of Oxford
Sort by
Refine Your Search
-
Listed
-
Country
-
Field
-
renewable award. You will lead a programme of research in the molecular mechanisms of cardiovascular disease, that may include a range of approaches including targeted genetic murine models, primary cell
-
the molecular mechanisms of ribosome biogenesis dysregulation in cancer. This full-time fixed-term post is funded by Cancer Research UK for 1 year. The actual starting salary offered will be based
-
, University of Oxford to study the interplay of ADP-ribosylation and ubiquitylation signalling in regulation of immunity and genome stability. The post-holder will be responsible for managing own academic
-
and leading a programme of numerical simulations relating to all aspects of our research on P-MoPAs; using particle-in-cell computer codes hosted on local and national high-performance computing
-
and Prof Paul Shearing. The post is funded through a strategic research partnership and is fixed term for up to 2 years. To support the programme, the post holder will be required to carry out research
-
Institute for Molecular and Computational Medicine (IMCM). You will test GSK assets and targets in established models of podocyte and mesangial cell pathology relevant to glomerular diseases. You will
-
We are seeking a talented and motivated researcher to join the Mead Group to contribute to a major research programme focused on characterisation of in vivo models of myeloid neoplasms and
-
We are seeking a talented and motivated researcher to join the Mead Group to contribute to a major research programme, focused on understanding and preventing disease progression in
-
We are seeking to appoint an enthusiastic and well-trained Research Assistant to join Prof. Sumana Sanyal’s group, based at the Sir William Dunn School of Pathology, University of Oxford. This post
-
A one-year Research Assistant position is available in Prof Ivan Ahel’s group based in the Sir William Dunn School of Pathology, University of Oxford to study ADP-ribosylation signalling in DNA